# Feature Specification: Osteo Vision Software Platform Target

**Feature Branch**: `[001-software-platform-target]`

**Created**: 2026-06-15

**Status**: Draft

**Input**: User description: "Define the project target from `software_focused_realistic_platform_zh.md`."

## Project Scope Alignment *(mandatory)*

**Platform Layer**: cross-cutting

**Competition Value**: supports pseudo-color fluorescence enhancement, AI-assisted review,
and standardized output/collaboration

**Medical Safety Boundary**: the platform remains a research and competition prototype,
keeps physician review as the final decision layer, and avoids automatic diagnosis or
unsupported clinical claims

**Out of Scope**: device SDKs, hospital integrations, full patient management, and
automatic clinical diagnosis

## User Scenarios & Testing *(mandatory)*

### User Story 1 - Review a dual-channel case (Priority: P1)

As a surgeon or reviewer, I can open a case containing white-light and fluorescence inputs,
inspect fused evidence, and identify the main suspicious region for review.

**Why this priority**: This is the core value of the platform and the first thing a reviewer
expects to see in a realistic intraoperative workflow.

**Independent Test**: Open a representative sample case and confirm that fused views, quality
flags, and a suspicious-region summary are shown before any export step.

**Acceptance Scenarios**:

1. **Given** valid dual-channel inputs, **When** the case is opened, **Then** the system shows
   fused views, a quality summary, and a candidate-region summary.
2. **Given** a weak, mismatched, or overexposed input pair, **When** the case is opened, **Then**
   the system flags low confidence or low usability instead of presenting a strong conclusion.

---

### User Story 2 - Refine regions with physician review (Priority: P2)

As a reviewer, I can draw or adjust regions of interest, accept or reject candidate regions, and
see the quantitative summary update with the review state.

**Why this priority**: The platform must preserve a human review boundary and let the reviewer
correct or confirm candidate findings.

**Independent Test**: Create or modify a region on a sample case and verify that the review state
and quantitative summary update consistently.

**Acceptance Scenarios**:

1. **Given** a candidate region, **When** the reviewer accepts it, **Then** the region is saved
with an accepted review state.
2. **Given** a candidate region, **When** the reviewer changes the region or thresholds, **Then**
   the updated state is recorded and the summary reflects the change.

---

### User Story 3 - Export an evidence bundle (Priority: P3)

As a researcher or platform administrator, I can export a case package containing the key
visuals, quantitative summary, review states, and report for sharing or later review.

**Why this priority**: The competition requires evidence, not just on-screen analysis.

**Independent Test**: Complete a reviewed sample case and verify that the exported package contains
the required artifacts and reproduces the reviewed state.

**Acceptance Scenarios**:

1. **Given** a reviewed case, **When** export is requested, **Then** the system produces a
complete evidence bundle with the expected artifacts.
2. **Given** a case with unresolved quality issues, **When** export is requested, **Then** the
system includes the warnings and low-confidence state in the exported output.

---

### Edge Cases

- What happens when the white-light and fluorescence inputs do not match in size, timing, or
  content?
- How does the platform behave when the fluorescence signal is too weak, too bright, blurred, or
  partly blocked?
- What happens when no candidate region is found but the reviewer still needs a report?
- How are conflicting reviewer actions handled when a region is accepted and later modified?
- What happens when export is interrupted before all artifacts are written?

## Requirements *(mandatory)*

### Functional Requirements

- **FR-001**: The platform MUST allow a user to create or open a case from at least one white-light
  input and one fluorescence input, with optional acquisition metadata.
- **FR-002**: The platform MUST show fused visual evidence and quality flags for valid, low-confidence,
  and unusable inputs.
- **FR-003**: The platform MUST allow a reviewer to define one or more regions of interest and view
  quantitative summaries for each region.
- **FR-004**: The platform MUST present candidate regions or risk regions that can be marked as
  review-required, accepted, modified, or rejected.
- **FR-005**: The platform MUST preserve reviewer decisions and case provenance so the final report
  reflects the reviewed state.
- **FR-006**: The platform MUST export an evidence bundle that includes visual outputs, quantitative
  summaries, and a structured report for each completed case.
- **FR-007**: The platform MUST include research-prototype disclaimers and MUST avoid language that
  presents the output as automatic diagnosis or definitive surgical instruction.
- **FR-008**: The platform MUST preserve the same user-facing case workflow when an approved analysis
  method is replaced with another approved analysis method.

### Key Entities *(include if feature involves data)*

- **Case**: A single de-identified case workspace, including inputs, status, and outputs.
- **Input Pair**: The white-light and fluorescence materials used for a case, plus optional metadata.
- **Region of Interest**: A user-defined area selected for review or quantification.
- **Candidate Region**: A proposed suspicious or risk region awaiting review.
- **Review State**: The current reviewer decision for a region or case.
- **Quality Flag**: A status that describes input usability, signal strength, alignment, or artifact risk.
- **Evidence Bundle**: The exported package of visuals, summaries, and report material for a case.
- **Analysis Run**: A single processing pass that produces the visible outputs and summary results.

### Evidence Artifacts *(include if feature produces outputs)*

- **Fusion View**: The combined white-light and fluorescence visual evidence for a case.
- **Quantitative Summary**: The measured summary for selected regions and the whole case.
- **Report Package**: The structured case report and export bundle for later review.

## Success Criteria *(mandatory)*

### Measurable Outcomes

- **SC-001**: In representative test cases, users can complete the full import → review → export
  flow with all required artifacts present.
- **SC-002**: In tested weak-signal, mismatched, overexposed, or blurred cases, the platform marks
  the case as low-confidence before final export.
- **SC-003**: Reviewers can accept, modify, or reject candidate regions, and the exported report
  reflects the final review state.
- **SC-004**: Every exported case includes fused visual evidence, a quantitative summary, a review
  record, and a research-prototype disclaimer.
- **SC-005**: No checked output contains unsupported automatic diagnosis language or claims of
  definitive clinical decision-making.

## Assumptions

- The initial target uses offline or uploaded dual-channel inputs rather than live device acquisition.
- A human reviewer remains part of every case workflow.
- Single-frame and short-sequence cases are both valid inputs for the target platform.
- The selected analysis method may change over time without changing the case-level workflow.
